Subgroup analysis by treatment group | Apixaban | Placebo | |||
---|---|---|---|---|---|
Events | Patients | Events | Patients | RR (95% CI) | |
Overall |
|
||||
Apixaban, 2.5 mg | 32 | 840 | 96 | 829 |
|
Apixaban, 5 mg | 34 | 813 |
|
||
Weight, kg |
|
||||
≤60 |
|
||||
Apixaban, 2.5 mg | 4 | 58 | 9 | 48 |
|
Apixaban, 5 mg | 4 | 59 |
|
||
>60 |
|
||||
Apixaban, 2.5 mg | 28 | 780 | 87 | 778 |
|
Apixaban, 5 mg | 30 | 751 |
|
Favors apixaban
Apixaban 2.5 mg BID
Apixaban 2.5 mg BID
Favors placebo
Apixaban 5 mg BID
Apixaban 5 mg BID